標(biāo)題: Titlebook: Biomarkers of Cardiometabolic Risk, Inflammation and Disease; Filipe Palavra,Flávio Reis,Armando Sena Book 2015 Springer International Pub [打印本頁] 作者: 五個(gè) 時(shí)間: 2025-3-21 19:17
書目名稱Biomarkers of Cardiometabolic Risk, Inflammation and Disease影響因子(影響力)
書目名稱Biomarkers of Cardiometabolic Risk, Inflammation and Disease影響因子(影響力)學(xué)科排名
書目名稱Biomarkers of Cardiometabolic Risk, Inflammation and Disease網(wǎng)絡(luò)公開度
書目名稱Biomarkers of Cardiometabolic Risk, Inflammation and Disease網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Biomarkers of Cardiometabolic Risk, Inflammation and Disease被引頻次
書目名稱Biomarkers of Cardiometabolic Risk, Inflammation and Disease被引頻次學(xué)科排名
書目名稱Biomarkers of Cardiometabolic Risk, Inflammation and Disease年度引用
書目名稱Biomarkers of Cardiometabolic Risk, Inflammation and Disease年度引用學(xué)科排名
書目名稱Biomarkers of Cardiometabolic Risk, Inflammation and Disease讀者反饋
書目名稱Biomarkers of Cardiometabolic Risk, Inflammation and Disease讀者反饋學(xué)科排名
作者: albuminuria 時(shí)間: 2025-3-21 22:49
Biomarkers of Cardiometabolic Risk, Inflammation and Disease作者: 慎重 時(shí)間: 2025-3-22 03:26 作者: 撫育 時(shí)間: 2025-3-22 04:53 作者: Glower 時(shí)間: 2025-3-22 11:10 作者: Moderate 時(shí)間: 2025-3-22 13:12 作者: 玉米 時(shí)間: 2025-3-22 18:54
Konstruieren sicherheitsgerechter Produkteith potential use in ischemic stroke, namely, in diagnosis, grading of severity, identification of subtypes, and prediction of outcome or recurrence. A special emphasis will be placed on the role of inflammation in stroke, as it plays a key role in the cascade of events leading to progression of isc作者: BLAZE 時(shí)間: 2025-3-22 21:50
,Gef?hrdungen und Risiken im Arbeitssystem,kers of morbidity and mortality, is an emergent area of research in the clinical area of nephrology. The more promising new biomarkers of kidney function, of the pathophysiological process underlying renal impairment, and of the associated cardiovascular risk are reviewed. Because inflammation is a 作者: Throttle 時(shí)間: 2025-3-23 02:45 作者: Recess 時(shí)間: 2025-3-23 08:49 作者: outset 時(shí)間: 2025-3-23 12:06 作者: Cardioplegia 時(shí)間: 2025-3-23 16:27
978-3-319-36236-6Springer International Publishing Switzerland 2015作者: 索賠 時(shí)間: 2025-3-23 20:33
Filipe Palavra,Flávio Reis,Armando SenaSystematic coverage of advances in cardiometabolic risk research.Compares emergent and classical cardiometabolic risk biomarkers.Discusses clinical relevance of cardiometabolic risk作者: 寄生蟲 時(shí)間: 2025-3-24 01:08
http://image.papertrans.cn/b/image/187828.jpg作者: 倫理學(xué) 時(shí)間: 2025-3-24 03:27
Inflammation Biomarkers and Cardiometabolic Risk,elp in identifying patients at high risk for future cardiovascular events, to improve diagnostic and prognostic abilities, and to monitor disease activity and efficacy of therapy. Acute-phase reactants, pro- and anti-inflammatory cytokines, cell adhesion molecules, chemokines, and other mediators in作者: 浮雕寶石 時(shí)間: 2025-3-24 10:29 作者: extinguish 時(shí)間: 2025-3-24 10:55
Diabetes Mellitus and Metabolic Syndrome,hile there are still gaps in medical knowledge about the pathophysiological mechanisms leading to the development of both conditions, a significant effort has been made to study them in detail. Inflammation has been recognized as a major player in all this, and the advancement of knowledge in this a作者: Flu表流動(dòng) 時(shí)間: 2025-3-24 17:26 作者: Compatriot 時(shí)間: 2025-3-24 20:59 作者: 變化無常 時(shí)間: 2025-3-25 01:09 作者: anesthesia 時(shí)間: 2025-3-25 07:23 作者: 儲(chǔ)備 時(shí)間: 2025-3-25 07:35 作者: badinage 時(shí)間: 2025-3-25 12:02 作者: amyloid 時(shí)間: 2025-3-25 19:33
Konstruieren sicherheitsgerechter Produkterea has been fruitful. This chapter will address the inflammatory mechanisms underlying these entities, starting with a more mechanistic and molecular perspective and ending in a more clinical setting.作者: helper-T-cells 時(shí)間: 2025-3-25 23:41 作者: 責(zé)難 時(shí)間: 2025-3-26 03:20
Konstruieren sicherheitsgerechter Produkteenesis throughout the whole process. Circulating inflammatory cytokines foster early vascular dysfunction as well as subclinical structural lesions, plaque rupture and thrombosis. Several biomarkers of atherosclerosis have been identified in rheumatic diseases. With few exceptions, their applicability in clinical practice is still marginal.作者: pulse-pressure 時(shí)間: 2025-3-26 05:12 作者: Commission 時(shí)間: 2025-3-26 11:20
Inflammation Biomarkers and Cardiometabolic Risk,volved in the pathogenesis of atherosclerosis have been shown to have predictive value to determine future cardiovascular events and/or death, but until now, none, with the exception of hsCRP, has demonstrated additive value to the Framingham Risk Score.作者: 受人支配 時(shí)間: 2025-3-26 15:52
Cardiovascular Disease, It is not clear yet if inflammation occurs as a cause or a consequence of AF, but several inflammatory markers are elevated in AF and correlate to the outcomes of different rhythm control strategies and thrombogenesis.作者: 設(shè)施 時(shí)間: 2025-3-26 18:12
Diabetes Mellitus and Metabolic Syndrome,rea has been fruitful. This chapter will address the inflammatory mechanisms underlying these entities, starting with a more mechanistic and molecular perspective and ending in a more clinical setting.作者: 荒唐 時(shí)間: 2025-3-26 22:22 作者: 合法 時(shí)間: 2025-3-27 04:02 作者: Dissonance 時(shí)間: 2025-3-27 06:20 作者: 沖突 時(shí)間: 2025-3-27 10:43 作者: Campaign 時(shí)間: 2025-3-27 16:59 作者: 收藏品 時(shí)間: 2025-3-27 19:54
linical relevance of cardiometabolic risk.This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical 作者: 懦夫 時(shí)間: 2025-3-28 00:08 作者: 表示問 時(shí)間: 2025-3-28 03:29
